Home › Calculator › NVSEF Dividend Calculator 2026
NVSEF Dividend DRIP Calculator 2026
3.02% YieldHealthcareNovartis AG · OTC
Price: $156.89 · Annual div: $4.74/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When NVSEF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your NVSEF snowball 📈
$10,000 in NVSEF → $245.8K in 10 years · $421.42/month
About Novartis AG (NVSEF) — Dividend Analysis 2026
Novartis AG, a global pharmaceutical enterprise established in 1996 and based in Basel, Switzerland, is engaged in the entire lifecycle of healthcare products, from research and development to manufacturing and worldwide commercialization. The company's operations are divided into two main divisions: Innovative Medicines and Sandoz. The Innovative Medicines segment is dedicated to providing advanced prescription medications to both patients and healthcare professionals. Its extensive product portfolio covers a wide range of therapeutic areas, including ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory conditions, cardiovascular health, renal diseases, and metabolism. Conversely, the Sandoz segment specializes in a comprehensive array of generic and biosimilar products. This involves the creation, production, and distribution of finished dosage form medicines, as well as active ingredients and small molecule pharmaceuticals for external partners. Sandoz also supplies generic drugs for retail, anti-infectives, and crucial active pharmaceutical ingredients (APIs) and intermediates, particularly antibiotics. Additionally, this division is involved in developing protein-based and other biotechnology products, such as biosimilars, and offers biotechnology manufacturing services. Novartis AG also pursues strategic collaborations. It has a licensing and collaboration agreement with Alnylam Pharmaceuticals concerning the development, production, and commercialization of inclisiran. Moreover, the company maintains a clinical partnership with Kura Oncology, Inc. to assess the combined efficacy of Tipifarnib and Alpelisib in treating head and neck squamous cell carcinoma patients.
Compare NVSEF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full NVSEF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open NVSEF position with:
🌍 NVSEF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold NVSEF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 3.02% | 0.22% | $302 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2.57% | -0.23% | $257 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2.42% | -0.38% | $242 / yr |
| 🇬🇧 UK ISA | 0% | 3.02% | 0.22% | $302 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2.76% | -0.04% | $276 / yr |
| 🇨🇦 TFSA | 0% | 3.02% | 0.22% | $302 / yr |
| 🇨🇦 CA Taxable | 25% | 2.27% | -0.53% | $227 / yr |
| 🇦🇺 Super (pension) | 15% | 2.57% | -0.23% | $257 / yr |
| 🇦🇺 AU Taxable | 30% | 2.11% | -0.69% | $211 / yr |
| 🇩🇪 DE Taxable | 26.375% | 2.22% | -0.58% | $222 / yr |
| 🇫🇷 FR Taxable | 30% | 2.11% | -0.69% | $211 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 NVSEF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $4.74/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 NVSEF Dividend Payment Schedule
NVSEF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 NVSEF vs Healthcare Benchmarks
How NVSEF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NVSEF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ NVSEF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where NVSEF earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NVSEF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Novartis AG (NVSEF) is currently trading at $156.89, 8% below its 52-week high. The current dividend yield is 3.02% based on an annual payout of $4.74 per share.
NVSEF (Novartis AG) — 3.02% Dividend Yield Analysis
Novartis AG (NVSEF) is a healthcare stock currently trading at $156.89 with a dividend yield of 3.02%. The company pays an annual dividend of $4.74 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, NVSEF has grown its dividend at a compound annual rate of 29.6%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.